Statements (57)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:beer
|
| gptkbp:activeDuring |
nicotine
|
| gptkbp:advertising |
social media campaigns
online marketing print ads television commercials |
| gptkbp:associatedWith |
support groups
behavioral therapy |
| gptkbp:availableIn |
multiple countries
various flavors |
| gptkbp:clinicalTrials |
studies on safety
studies on effectiveness studies on side effects |
| gptkbp:contraindication |
pregnancy
heart disease allergy to nicotine |
| gptkbp:dosageForm |
2 mg
4 mg |
| gptkbp:firstIntroduced |
1984
|
| gptkbp:formFactor |
patch
gum nasal spray inhaler lozenge |
| gptkbp:goal |
reduce cravings
reduce withdrawal symptoms |
| https://www.w3.org/2000/01/rdf-schema#label |
Nicorette
|
| gptkbp:manufacturer |
gptkb:Johnson_&_Johnson
|
| gptkbp:marketedAs |
over-the-counter medication
|
| gptkbp:packaging |
blister pack
box resealable_pouch |
| gptkbp:partOf |
public health initiatives
tobacco control efforts smoking cessation strategy healthcare_guidelines |
| gptkbp:regulates |
FDA_approved
|
| gptkbp:research |
demographic studies
user satisfaction cost-effectiveness long-term effectiveness comparative effectiveness |
| gptkbp:sideEffect |
dizziness
headache nausea insomnia mouth irritation |
| gptkbp:supports |
smoking cessation programs
healthcare_professionals quitlines |
| gptkbp:targetAudience |
smokers
|
| gptkbp:usedFor |
smoking cessation
|
| gptkbp:uses |
chew gum until flavor is gone
inhale through inhaler place patch on skin spray into nostrils suck lozenge until dissolved |